Monitoring the effects of medications in residential aged care (nursing home) using digital health technologies: insights from the ReMInDAR and ADEPT projects

Renly Lim, Monique Boord, Julian Soriano, Rebecca Bilton, Elizabeth E. Roughead

Research output: Contribution to journalReview articlepeer-review

Abstract

The adoption of technology, particularly for monitoring the effects of medications in residential aged care (nursing home), has been slow. Ageing populations have led to increased demand for residential aged care globally, resulting in a growing imperative to implement technological solutions to meet the complex healthcare and medication needs of older people in residential aged care. This commentary explores the potential for and the challenges associated with implementing technological interventions within residential aged care to improve monitoring of medication effects. Drawing on insights from two implementation trials, specifically the Reducing Medicine-induced Deterioration and Adverse Reactions and A Digitally Enabled Pharmacist Service to detecT medicine harms in residential aged care, we discuss the unique challenges and opportunities arising from the real-world applications of digital technologies for medication safety in aged care.

Original languageEnglish
Article numberafaf019
Number of pages5
JournalAge and Ageing
Volume54
Issue number3
DOIs
Publication statusPublished - Mar 2025

Keywords

  • adverse drug events
  • digital health
  • drug safety
  • mHealth
  • older people
  • physical activity

Fingerprint

Dive into the research topics of 'Monitoring the effects of medications in residential aged care (nursing home) using digital health technologies: insights from the ReMInDAR and ADEPT projects'. Together they form a unique fingerprint.

Cite this